A Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Synthetic Conjugated Estrogens, B (Enjuvia) 0.3 mg Tablets for the Treatment of Vulvovaginal Atrophy in Healthy Postmenopausal Women

Trial Profile

A Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Synthetic Conjugated Estrogens, B (Enjuvia) 0.3 mg Tablets for the Treatment of Vulvovaginal Atrophy in Healthy Postmenopausal Women

Completed
Phase of Trial: Phase III

Latest Information Update: 30 Aug 2013

At a glance

  • Drugs Conjugated estrogens (Primary)
  • Indications Atrophic vaginitis; Menopausal syndrome
  • Focus Registrational; Therapeutic Use
  • Sponsors Duramed Pharmaceuticals Inc
  • Most Recent Events

    • 03 Oct 2009 Results were presented at the 20th Annual Meeting of the North American Menopause Society.
    • 01 Oct 2008 Results have been published in Fertility and Sterility.
    • 26 Oct 2007 Status change from in progress to completed
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top